InsidersTradesSigma
Follow the ProKidney Corp share price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €730.5m. The latest transaction was filed on 18 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Brian Pereira. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
ProKidney Corp is a company focused on developing treatments for kidney diseases. It is listed on the NASDAQ under the ticker PROK.